Xenon Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.

CEO

Ian C. Mortimer

CEOIan C. Mortimer

Employees

327

Employees327

Headquarters

Burnaby, British Columbia

HeadquartersBurnaby, British Columbia

Founded

1996

Founded1996

Employees

327

Employees327

XENE Key Statistics

Market cap

2.43B

Market cap2.43B

Price-Earnings ratio

-9.84

Price-Earnings ratio-9.84

Dividend yield

—

Dividend yield—

Average volume

1.12M

Average volume1.12M

High today

$32.01

High today$32.01

Low today

$30.74

Low today$30.74

Open price

$30.91

Open price$30.91

Volume

570.75K

Volume570.75K

52 Week high

$46.00

52 Week high$46.00

52 Week low

$26.74

52 Week low$26.74

Analyst ratings

100%

of 19 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Xenon Pharmaceuticals

Why Robinhood?

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. Show more

XENE Key Statistics

Analyst ratings

100%

People also own

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.